Healthcare & Biotech

Brea, Calif. – September 12, 2026 -- Envista Holdings Corporation (NYSE: NVST) will participate in a fireside chat at the Baird 2026 Global Healthcare Conference on Tuesday, September 15, 2026, from 9:40 to 10:10 AM ET.

Envista confirms live webcast access for investors

A live audio webcast of the session, along with an archived replay, will be available in the Investors section of the Envista website.

Dental industry group operates more than 30 brands

Envista's portfolio includes DEXIS, Kerr, Nobel Biocare, and Ormco, spanning dental imaging, orthodontics, and implant technologies.

Warsaw, Ind. – September 12, 2026 -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) named three internal executives to newly restructured president roles effective October 1, as Group President Kevin Thornal exits the company on September 30 following a transition period.

Gary Campbell takes over commercial strategy across the Americas

Campbell, promoted to President, Americas, will oversee commercial execution in the United States, Canada and Latin America. He has served as vice president and general manager, Orthopedics – North America, since September 2024, and joined Zimmer Biomet in 2019 after prior sales and marketing roles at Enovis.

Grand Rapids, Mich. – – September 12, 2026 -- Shoulder Innovations, Inc. (NYSE: SI) has settled all outstanding patent litigation with Catalyst OrthoScience Inc., ending a legal dispute between the two shoulder-implant makers under confidential terms.

Shoulder Innovations resolves patent dispute with Catalyst OrthoScience under sealed terms

The settlement agreement closes all pending patent claims between Shoulder Innovations and Catalyst OrthoScience without disclosing financial or licensing terms.

CEO Rob Ball says the deal protects intellectual property tied to shoulder arthroplasty innovation

"We are pleased to have reached a resolution with Catalyst that provides an agreeable solution to this patent dispute," said Rob Ball, CEO of Shoulder Innovations. He said protecting intellectual property remains fundamental to ensuring continued investment benefits stakeholders, including surgeons and patients.

Topeka – September 12, 2026 -- A new 60-bed Behavioral Health Unit at the Shawnee County Jail in Topeka, Kansas, opened on August 24 following a three-year, $21 million construction project, expanding specialized care for pretrial detainees with mental health and substance use needs.

VitalCore Health Strategies backs 23,279-square-foot expansion

The addition was built to serve individuals awaiting trial who require mental health treatment, substance use support, suicide prevention, competency restoration, and other specialized services. VitalCore Health Strategies provides healthcare services at the facility under a partnership with the Shawnee County Department of Corrections that began in 2024.

Linköping – – September 12, 2026 -- Shareholders of Sectra AB (STO:SECTB) approved a combined dividend of SEK 2.30 per share at the medical imaging IT and cybersecurity company's Annual General Meeting held September 8, 2026.

Sectra sets record date for SEK 2.30 combined payout

The AGM resolved to distribute an ordinary dividend of SEK 1.30 per share plus an extraordinary dividend of SEK 1.00 per share, with remaining funds carried forward. The record date is September 10, 2026, and payment through Euroclear Sweden AB is expected September 15, 2026.

Berlin – September 12, 2026 -- More than 40% of unnecessary emergency dispatches in Germany stem from patients' lack of awareness about alternative care options, according to a survey of rescue workers commissioned by the Left party's Bundestag faction, as the federal government advances a reform plan centered on stricter patient triage for the 112 emergency line.

Rescue workers rank ignorance of care alternatives as the top cause of misdirected calls

The survey found that ambulance crews and paramedics identify unfamiliarity with non-emergency care channels -- such as general practitioners or pharmacies -- as the leading driver of avoidable 112 calls, cited in over 40% of responses. Cases range from patients calling about a tick bite to those reporting leg pain that has persisted for three weeks.

San Francisco – – September 11, 2026 -- Trust AI has wired VELMENI's FDA-cleared dental imaging AI directly into its Isaac PracticeOS platform, connecting radiographic diagnosis to a $299-per-month automated claims pipeline that has already recovered months of unbilled revenue at a California practice.

Isaac's agent swarm assembles claims the moment a dentist confirms a VELMENI finding

The integration places VELMENI for DENTISTS (V4D) 2D/3D radiographic analysis inside Isaac's RCM Hub, where automated agents identify payer-specific documentation requirements, select matching billing codes, and attach supporting radiographs before a claim is submitted. Every claim is reviewed by a licensed dentist and a billing specialist before it leaves the system. Trust AI CEO Bernard Casse said the company "wired it into the bloodstream" rather than treating the AI read as a standalone sidebar feature.

Danbury, Conn. – September 11, 2026 -- Perosphere Technologies Inc. announced that a clinical study evaluating its ClotChek point-of-care coagulometer has been published in the peer-reviewed journal Thrombosis and Haemostasis, confirming the device's ability to detect anticoagulation levels in patients on Factor Xa inhibitors apixaban and rivaroxaban.

Study confirms ClotChek detects DOAC anticoagulation at two clinical thresholds

The research measured ClotChek Clotting Time (CKCT) against anti-FXa drug levels in patients on direct oral anticoagulants, finding strong correlations when categorized by Medical Decision Limits. The device demonstrated the ability to identify clinically meaningful anticoagulation at both the >75 ng/mL and >30 ng/mL thresholds, including sensitivity at lower drug concentrations.

New York – September 11, 2026 -- Eligible, Inc. has completed its SOC 2 Type II examination for its Platform Services System with zero exceptions across all four Trust Services Categories evaluated: Security, Availability, Processing Integrity, and Confidentiality.

Independent assessor A-LIGN confirms full compliance across audit period

The examination, conducted by third-party assessor A-LIGN, evaluated the design and operating effectiveness of Eligible's controls over a defined audit period, covering the REST APIs, application infrastructure, and supporting services that process HIPAA-mandated healthcare financial transactions. These include eligibility verification (270/271), claims (837/276/277), remittance (835), and acknowledgements (TA1, 997, 999).

Delray Beach, Fla. – September 11, 2026 -- The global medical supplies market is projected to grow from $194.76 billion in 2026 to $248.03 billion by 2031, a compound annual growth rate of 7.39%, according to new research from MarketsandMarkets.

Asia Pacific outpaces global growth rate as diagnostic demand accelerates

Asia Pacific is set to register the fastest regional CAGR at 10.2% through 2031, outstripping the global average as healthcare infrastructure expands across the region. By product type, infusion and injectable supplies will grow fastest at a 9.0% CAGR, while diagnostic supplies held the largest share in 2025 and are expected to post the quickest growth of any category over the forecast period, driven by rising chronic and infectious disease burdens and expanding preventive screening programs.